XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Series A Preferred Stock.
Series A Preferred Stock
Series A Preferred Stock.
Class A Common Stock
Additional Paid-in Capital.
Accumulated Other Comprehensive Loss
Accumulated Deficit.
Series A Preferred Stock
Total
Beginning balance, value at Dec. 31, 2020     $ 6 $ 86,768 $ 5,192 $ (47,498)   $ 44,468
Beginning balance, shares at Dec. 31, 2020     53,343,518       167,972  
Shares issued for acquisition       404       404
Shares issued for acquisition (in shares)     142,882          
Stock options exercised       405       $ 405
Stock options exercised (in shares)     481,834         481,834
Warrants exercised       203       $ 203
Warrants exercised (in shares)     95,749          
Stock compensation       3,020       3,020
Foreign currency translation         (1,739)     (1,739)
Fixed dividends Preferred Series B       (951)       (951)
Net income (loss)           (6,659)   (6,659)
Conversion of accounts payable liabilities       1,626       1,626
Conversion of accounts payable liabilities (in shares)     793,375          
Conversion of debt obligations       13,783       $ 13,783
Conversion of debt obligations (in shares)     5,693,481          
Conversion of restricted shares (in shares)     760,060         760,060
Deemed contribution from Series B preferred       367       $ 367
Ending balance, value at Sep. 30, 2021     $ 6 105,625 3,453 (54,157)   54,927
Ending balance, shares at Sep. 30, 2021     61,310,899       167,972  
Beginning balance, value at Jun. 30, 2021     $ 6 100,559 5,461 (54,886)   51,140
Beginning balance, shares at Jun. 30, 2021     59,102,072       167,972  
Stock options exercised       159       $ 159
Stock options exercised (in shares)     162,400         162,000
Warrants exercised       152       $ 152
Warrants exercised (in shares)     75,000          
Stock compensation       1,161       1,161
Foreign currency translation         (2,008)     (2,008)
Fixed dividends Preferred Series B       (317)       (317)
Net income (loss)           729   729
Conversion of debt obligations       3,911       $ 3,911
Conversion of debt obligations (in shares)     1,755,009          
Conversion of restricted shares (in shares)     216,418         217,000
Ending balance, value at Sep. 30, 2021     $ 6 105,625 3,453 (54,157)   $ 54,927
Ending balance, shares at Sep. 30, 2021     61,310,899       167,972  
Beginning balance, value at Dec. 31, 2021     $ 6 110,867 3,728 (61,300)   53,301
Beginning balance, shares at Dec. 31, 2021 167,972   63,821,901          
Shares issued for acquisition       150       150
Shares issued for acquisition (in shares)     230,770          
Stock options exercised       69       $ 69
Stock options exercised (in shares)     193,841         193,841
Issuance of warrants and prefunded warrants       2,348       $ 2,348
Vesting of restricted share units (in shares)     1,995,871          
Warrants exercised (in shares)     352,940          
Issuance of stock     $ 1 2,352       2,353
Issuance of stock (in shares)     7,000,000          
Stock compensation       2,665       2,665
Foreign currency translation         (11,449)     (11,449)
Fixed dividends Preferred Series B       (952)       (952)
Net income (loss)           (1,725)   $ (1,725)
Conversion of debt obligations (in shares)     528,169          
Conversion of restricted shares (in shares)               1,995,871
Ending balance, value at Sep. 30, 2022     $ 7 117,499 (7,721) (63,025)   $ 46,760
Ending balance, shares at Sep. 30, 2022 167,972 167,972 74,123,492          
Beginning balance, value at Jun. 30, 2022     $ 7 112,352 (2,681) (66,130)   43,548
Beginning balance, shares at Jun. 30, 2022 167,972   66,207,717          
Shares issued for acquisition       150       $ 150
Shares issued for acquisition (in shares)     230,770          
Stock options exercised (in shares)               0
Issuance of warrants and prefunded warrants       2,348       $ 2,348
Vesting of restricted share units       11       11
Vesting of restricted share units (in shares)     332,065          
Warrants exercised (in shares)     352,940          
Issuance of stock       2,352       2,352
Issuance of stock (in shares)     7,000,000          
Stock compensation       603       603
Foreign currency translation         (5,040)     (5,040)
Fixed dividends Preferred Series B       (317)       (317)
Net income (loss)           3,105   $ 3,105
Conversion of restricted shares (in shares)               332,065
Ending balance, value at Sep. 30, 2022     $ 7 $ 117,499 $ (7,721) $ (63,025)   $ 46,760
Ending balance, shares at Sep. 30, 2022 167,972 167,972 74,123,492